Analysis Of Biological Materials Research Articles

Applications of Sample Preparation Techniques in the Analysis of New Psychoactive Substances

The global rise of new psychoactive substances (NPSs) poses challenges for their analysis in biological matrices due to their complex chemistries and short market lifespan. A comparative study for the simultaneous extraction, separation, and detection of 19 NPSs was conducted. Six solid-phase extraction (SPE) methods and one supported liquid extraction method (SLE) were compared for the extraction of analytes from blood, serum, plasma, and urine. Comparisons of four derivatization agents were conducted, at four temperatures and two incubation times. Extraction methods were assessed by precision, sensitivity, and extraction efficiency. Derivatizing agents were assessed on their selectivity and sensitivity, and a three-way ANOVA was conducted to determine statistical significance. CSDAU SPE cartridges were shown to be the most efficient when extracting analytes from blood, serum, and plasma, whereas Xcel I cartridges performed the strongest when extracting analytes from urine. SPE extraction efficiencies, when utilizing the best-performing cartridges, ranged from 49 to 119%. SLE successfully extracted all analytes from all matrices (ranging from 22 to 120%). Pentafluoropropionic anhydride: ethyl acetate was the most successful derivatizing agent, allowing all analytes to be detected, with the highest peak area responses and more unique spectra. The optimum temperature for incubation was 37 °C, with no statistical difference found between the two incubation times.

Follicular Fluid and Blood Monitorization of Infertility Biomarkers in Women with Endometriosis.

Infertility is recognized globally as a social disease and a growing medical condition, posing a significant challenge to modern reproductive health. Endometriosis, the third-most frequent gynecologic disorder, is one of the most common and intricate conditions that can lead to female infertility. Despite extensive research, the etiology, malignant transformation, and biological therapy of endometriosis remain unknown. Blood and follicular fluid are two matrices that have been carefully studied and can provide insights into women's health. These matrices are clinically significant because they contain metabolites closely associated with women's illness stage and reproductive outcomes. Nowadays, the application of metabolomic analysis in biological matrices may be able to predict the outcome of assisted reproductive technologies with greater precision. From a molecular viewpoint on reproductive health, we evaluate and compare the utilization of human follicular fluid and blood as matrices in analysis for diagnostic and assisted reproductive technology (ART) predictors of success for endometriosis patients. In the follicular fluid (FF), plasma, and serum of endometriosis-affected women, researchers identified dysregulations of oxidative stress, upregulation of several immune factors, and aberrations in energy metabolic pathways. The altered signatures negatively correlate with the overall oocyte and embryo quality and fertilization rate.

Dispersive liquid-liquid microextraction (DLLME) for determination of tricyclic antidepressants in whole blood and plasma samples and analysis by liquid chromatography with diode array detector (LC-DAD)

Microextractions have been developed for the tricyclic antidepressants (TCAs) analysis in biological matrices, including dispersive liquid-liquid microextraction (DLLME). The proposed DLLME employed 490 µL of biological sample (whole blood or plasma), which were added 15 mg of NaCl, 10 µL of medazepam as internal standard (10 µg/mL) and 100 µL of 2 M NaOH. This mixture was homogenized by vortex (2800 rpm/10 s) and 400 µL of hexane (extractor solvent) with 600 µL of methanol (dispersing solvent) were added to the sample. After the vortex step (2800 rpm/5 s), an ultrasonic bath for 300 s was employed. Then, this content was centrifuged (10 min/10000 rpm), organic phase was collected and dried under air flow. After, 30 µL of the mobile phase was used for resuspension and 20 µL is injected into LC-DAD. This method was optimized and fully validated according to UNODC and SWGTOX guidelines, reaching limits of detection equivalent to analytical methodologies that employ mass spectrometry (MS). Also, it was applied in real cases involving suspected exposure to TCAs. So, the developed DLLME for the determination of TCAs in whole blood and plasma samples proved to be a simple, reliable, robust and reproducible method that can be used in toxicology and clinical laboratories.

One Medicine for All

Innovation in pharmaceutical science has become a particular concern for individual health. For a long time, the practice of "One-Size-Fits-All" medication has been common in healthcare services worldwide, making analytical methods crucial to drug analysis in biological matrices. Suitable methods for determining drug levels in biological matrices aim to prevent medication dosage errors. Every person's condition is different, and their diseases vary, caused by genetics, environment, and lifestyle. Personalized medicine is often described as "the right patient, the right drug, at the right dose, at the right time." This study used a qualitative literature review method, where sources or literature in national and international journals were searched through online media. The analysis results explain that the role of the biological environment is more significant than others in vector-borne diseases, and the role of the genetic nucleus is more significant than others in hereditary diseases. Due to the numerous ecological interactions, we can often change the spread of disease by changing certain aspects of human interaction with their environment without direct intervention in the cause of the disease. The implementation of the science from "Bench to bedside" and "From clinic to community" assumes the provision of long-distance healthcare services by healthcare professionals using information technology, where the implementation of telemedicine (Systematic Review) in healthcare services is crucial, considering some of the problems that arise from manual services. One of the technical implementations of telemedicine is to optimize personalized medicine, which also involves implementing pharmacogenetics approaches in hospitals.

Determination of inorganic As, DMA and MMA in marine and terrestrial tissue samples: a consensus extraction approach

Environmental context Arsenic can be found in all environmental compartments in a large number of chemical forms of varying toxicity. We performed an inter-laboratory comparison study focusing on quantitation of some of the most toxic arsenic forms in seven different biological materials and found very good agreement among the submitted results. Certification of the studied materials will provide suitable quality control samples for environmentally relevant concentrations of arsenic in food products and biota.Rationale Arsenic (As) speciation analysis in biological matrices has been performed for several decades; however, there are very few matrix certified reference materials available for the validation of analytical methods. The literature data on the mass fractions of As species in the existing certified reference materials are inconsistent and suggest method extraction dependency.Methodology In the present study, an international round-robin study was organised to identify the possible sources of discrepancies in quantitation of several As species in different matrices of biological reference materials: one plant tissue, three marine and three terrestrial biological tissues. Each participating laboratory was provided with a set of identical calibration standard solutions, and analysed the samples by following a common group extraction method as well as using an in-house protocol.Results The results showed that significant biases can be introduced by insufficient verification of the analyte’s mass fractions in the calibration standard solutions. The choice of extraction method seems to have very little impact on the quantitation of As species in the studied plant and terrestrial biological tissues. However, following a prescribed extraction method led to significant reduction of uncertainties in more complex samples such as marine animal tissues.Discussion Some differences in the mass fractions of As species extracted from marine animal tissues in water (with and without H2O2) were observed and should be further investigated. Despite the variety of extraction methods used, very good agreement between reported mass fractions was achieved and the combined consensus values will be published as certified reference values of As species in the studied materials.

Rapid determination of polyethoxylated tallow amine surfactants in human plasma by LC-MSMS

The potential exposure to the widely used glyphosate-based herbicides, including attempted suicide by ingestion, is of world-wide concern. Whilst the major focus to date has been on managing exposure to the active ingredient glyphosate, it is now recognised that a common major ‘inert’ surfactant ingredient, polyethoxylated tallow amine (POEA) and related compounds, may be more toxic. However, the information on the toxicokinetics of POEA surfactants after exposure is limited, in part, due to the lack of suitable methods for their analysis in biological matrices. We therefore developed and validated a robust LC-MSMS method that allowed, for the first time, a rapid analysis of 11 POEA homologues in human plasma. Chromatographic separation was achieved on a Kinetex EVO C18 column under a 5 min gradient elution with mobile phase A containing water/acetonitrile/formic acid (95:5:0.1, v/v/v) and mobile phase B containing acetonitrile/water/formic acid (95:5:0.1, v/v/v). Amlodipine was chosen as the internal standard (IS) for this assay. Amlodipine-d4 would be an ideal alternative IS to expand the applicability of the established method especially in antihypertensive patients. Multiple reaction monitoring (MRM) methods were optimized for 11 POEA homologues and the IS. Sample pre-treatment was performed using simple protein precipitation with methanol at a ratio of 4:1, requiring only 20 μL plasma. The validated method showed good specificity, accuracy and precision with lower limits of quantification (LLOQ) ranging from 0.35 to 10.8 ng mL−1 for all selected POEA homologues. The method was then used to measure concentrations of the various POEA surfactants in more than 600 human plasma samples from 151 patients admitted to hospital with acute glyphosate intoxication. The highest concentrations ranged from 1.07 ng mL−1 for C18u(EO)4–362.70 ng mL−1 for C16s(EO)2. The analysis of POEA surfactants plasma concentrations as described here underpins the assessment of POEA internal exposure and the relationships between POEA related glyphosate toxicity and the extent of poisoning.

Fabric Phase Sorptive Extraction (FPSE) as an efficient sample preparation platform for the extraction of antidepressant drugs from biological fluids

• Fast method for simultaneous analysis of seven ADs. • Analysis of biological matrices. • FPSE application in conventional and unconventional matrices. • Method suitable for TDM of ADs. • Performances comparable to a more complex and expensive instrumentations. The quantification and interpretation of drug concentrations in biological matrices to optimize pharmacotherapy and to perform the therapeutic drug monitoring (TDM) is particularly important for compounds with narrow therapeutic ranges, known to cause adverse effects. In these cases, the biomonitoring is essential to avoid the toxicity and side effects. In this study, an innovative Fabric Phase Sorptive Extraction (FPSE) followed by high performance liquid chromatography-photodiode array detection (FPSE–HPLC–PDA) method was optimized and validated for the extraction and quantitative evaluation of seven antidepressant drugs (ADs, venlafaxine, citalopram, paroxetine, fluoxetine, sertraline, amitriptyline, and clomipramine) in human whole blood, urine, and saliva samples. The best chromatographic separation was obtained using a reverse phase column and ammonium acetate (50 mM, pH 5.5) and acetonitrile (AcN) as mobile phases, with 0.3% of triethylamine (TEA) for the best peak shape. The used sample preparation technique, FPSE, developed in 2014, has offered numerous advantages such as low consumption of organic solvents, no sample pretreatment, and reduced overall sample preparation time. Among all tested membranes, sol-gel carbowax (CW 20 M) sorbent, coated on cellulose FPSE media, was the most efficient. The developed method provides satisfactory limit of detection of 0.06 μg/mL for all analytes except for venlafaxine that was 0.04 μg/mL. Both RSD% and BIAS% gave values below ±15%, according to current guidelines. Finally, real samples analyzes were carried out, comparing the obtained data with the anamnestic data of the subjects, confirmed the validity of the method.

Interlaboratory comparison investigations (ICIs) and external quality assurance schemes (EQUASs) for flame retardant analysis in biological matrices: Results from the HBM4EU project

The European Human Biomonitoring Initiative (HBM4EU) is coordinating and advancing human biomonitoring (HBM). For this purpose, a network of laboratories delivering reliable analytical data on human exposure is fundamental. The analytical comparability and accuracy of laboratories analysing flame retardants (FRs) in serum and urine were investigated by a quality assurance/quality control (QA/QC) scheme comprising interlaboratory comparison investigations (ICIs) and external quality assurance schemes (EQUASs).This paper presents the evaluation process and discusses the results of four ICI/EQUAS rounds performed from 2018 to 2020 for the determination of ten halogenated flame retardants (HFRs) represented by three congeners of polybrominated diphenyl ethers (BDE-47, BDE-153 and BDE-209), two isomers of hexabromocyclododecane (α-HBCD and γ-HBCD), two dechloranes (anti-DP and syn-DP), tetrabromobisphenol A (TBBPA), decabromodiphenylethane (DBDPE), and 2,4,6-tribromophenol (2,4,6-TBP) in serum, and four metabolites of organophosphorus flame retardants (OPFRs) in urine, at two concentration levels. The number of satisfactory results reported by laboratories increased during the four rounds. In the case of HFRs, the scope of the participating laboratories varied substantially (from two to ten) and in most cases did not cover the entire target spectrum of chemicals. The highest participation rate was reached for BDE-47 and BDE-153. The majority of participants achieved more than 70% satisfactory results for these two compounds over all rounds. For other HFRs, the percentage of successful laboratories varied from 44 to 100%. The evaluation of TBBPA, DBDPE, and 2,4,6-TBP was not possible because the number of participating laboratories was too small. Only seven laboratories participated in the ICI/EQUAS scheme for OPFR metabolites and five of them were successful for at least two biomarkers. Nevertheless, the evaluation of laboratory performance using Z-scores in the first three rounds required an alternative approach compared to HFRs because of the small number of participants and the high variability of experts' results. The obtained results within the ICI/EQUAS programme showed a significant core network of comparable European laboratories for HBM of BDE-47, BDE-153, BDE-209, α-HBCD, γ-HBCD, anti-DP, and syn-DP. On the other hand, the data revealed a critically low analytical capacity in Europe for HBM of TBBPA, DBDPE, and 2,4,6-TBP as well as for the OPFR biomarkers.

Ultra-High Performance Liquid Chromatography-High Resolution Mass Spectrometry and High-Sensitivity Gas Chromatography-Mass Spectrometry Screening of Classic Drugs and New Psychoactive Substances and Metabolites in Urine of Consumers.

The use of the new psychoactive substances is continuously growing and the implementation of accurate and sensible analysis in biological matrices of users is relevant and fundamental for clinical and forensic purposes. Two different analytical technologies, high-sensitivity gas chromatography-mass spectrometry (GC-MS) and ultra-high-performance liquid chromatography-high-resolution mass spectrometry (UHPLC-HRMS) were used for a screening analysis of classic drugs and new psychoactive substances and their metabolites in urine of formed heroin addicts under methadone maintenance therapy. Sample preparation involved a liquid-liquid extraction. The UHPLC-HRMS method included Accucore™ phenyl Hexyl (100 × 2.1 mm, 2.6 μm, Thermo, USA) column with a gradient mobile phase consisting of mobile phase A (ammonium formate 2 mM in water, 0.1% formic acid) and mobile phase B (ammonium formate 2 mM in methanol/acetonitrile 50:50 (v/v), 0.1% formic acid) and a full-scan data-dependent MS2 (ddMS2) mode for substances identification (mass range 100–1000 m/z). The GC-MS method employed an ultra-Inert Intuvo GC column (HP-5MS UI, 30 m, 250 µm i.d, film thickness 0.25 µm; Agilent Technologies, Santa Clara, CA, USA) and electron-impact (EI) mass spectra were recorded in total ion monitoring mode (scan range 40–550 m/z). Urine samples from 296 patients with a history of opioid use disorder were examined. Around 80 different psychoactive substances and/or metabolites were identified, being methadone and metabolites the most prevalent ones. The possibility to screen for a huge number of psychotropic substances can be useful in suspected drug related fatalities or acute intoxication/exposure occurring in emergency departments and drug addiction services.

A powerful combination of quadruple isotope dilution strategy with dispersive magnetic solid phase extraction for the accurate and precise multi-analyte determination of tadalafil, sildenafil, avanafil and vardenafil in human plasma and urine samples using LC-ESI-Tandem MS

Trace organic analysis in biological matrices plays a critical role in clinical studies. To achieve a reliable evaluation of clinical practice, many analytical improvements have been introduced to overcome the difficulties/errors in the steps of the analysis procedure. In this study, quadrupole isotope dilution mass spectrometry was combined with dispersive magnetic solid phase extraction to achieve inherent accuracy and precision at trace levels. The lower limits of detection and quantification values of analytes ranged between 0.42–0.84 ng/g and 1.39–2.80 ng/g, respectively with percent relative standard deviations (%RSDs) of 0.65–1.24%. The combined method was applied for simultaneous determination of selected erectile drugs including sildenafil, tadalafil, vardenafil and avanafil in human urine and plasma samples by using commercially available isotopic analogues of these compounds. Great percent recovery values between 97.50–99.57% and 98.26–100.92% with%RSDs of 1.19–1.96% and 0.49–1.95% respectively for plasma and urine samples were obtained. The proposed method is simple, environmentally friendly, requires less laborious sampling and provides superior accuracy and precision at low levels of analytes. Furthermore, the proposed method also provides economical advantages. The synthesis procedure of magnetic sorbent is easy, low cost and does not require high consumption of toxic chemicals. Additionally, the isotopically enriched standards of target compounds are accessible, do not have high costs and the method requires only small amounts of these chemicals.

Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.

Synthetic cannabinoids (SCs) remain one of the largest groups of new psychoactive substances (NPS) on the European drug market. Although the number of new derivatives occurring on the market has dropped in the last two years, newly emerging NPS still represent a challenge for laboratories performing forensic drug analysis in biological matrices. The newly emerged SC 4F-MDMB-BINACA has been reported by several law enforcement agencies in Europe and the USA since November 2018. This work aimed at revealing urinary markers to prove uptake of 4F-MDMB-BINACA and differentiate from the use of structurally similar SCs. Phase-I metabolites detected in human urine specimens were confirmed by phase-I metabolites generated in vitro using a pooled human liver microsomes (pHLM) assay. Seized materials and test-purchased "legal high" products were analyzed by gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-quadrupole-time-of-flight-mass spectrometry (LC-qToF-MS). Human urine specimens and pHLM assay extracts were measured with liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) and confirmed by LC-qToF-MS. In January 2019, the Institute of Legal Medicine in Erlangen (Germany) identified 4F-MDMB-BINACA in three herbal blends. During the same time period, the described SC was identified in a research chemical purchased online. Investigation of phase-I metabolism led to the metabolites M10 (ester hydrolysis) and M11 (ester hydrolysis and dehydrogenation) as reliable urinary markers. Widespread distribution on the German drug market was proven by analysis of urine samples from abstinence control programs and by frequent detection of 4F-MDMB-BINACA in "herbal blends" and "'research chemicals" purchased via the Internet.

Recent trends in analysis of nanoparticles in biological matrices.

The need to assess the human and environmental risks of nanoparticles (NPs) has prompted an adaptation of existing techniques and the development of new ones. Nanoparticle analysis poses a great challenge as the analytical information has to consider both physical (e.g. size and shape) and chemical (e.g. elemental composition) state of the analyte. Furthermore, one has to contemplate the transformation of NPs during the sample preparation and provide sufficient information about the new species derived from such alteration. Traditional techniques commonly used for NP analysis such as microscopy and light scattering are still frequently used for NPs in simple matrices; however, they have limitations in the analysis of complex environmental and biological samples. On the other hand, recent improvements in data acquisition frequencies and reduction of settling time of ICP-MS brought inorganic mass spectrometry into the forefront of NPs analysis. However, with the increasing demand of analytical information related to NPs, emerging techniques such as enhanced darkfield hyperspectral imaging, nano-SIMS and mass cytometry are in their way to fill the gaps. This trend review presents and discusses the state-of-the-art analytical techniques and sample preparation methods for NP analysis in biological matrices. Graphical abstract ᅟ.

Using gold nanorod-based colorimetric sensor for determining chromium in biological samples

Hexavalent chromium can inflict several health issues in comparison to other oxidation states of chromium. Anisotropic gold nanorods (AuNRs) have size-tunable optical properties, and hence, the spectral shift noted with increasing Cr6+ concentrations can be employed for the development of a Cr6+ sensor. The present work involves the usage of BSA-coated AuNRs for Cr6+ detection in biological samples by utilizing hydrobromic acid. AuNRs, upon interaction with Cr6+, can exhibit decreased aspect ratio and transform to nanospheres for higher Cr6+ concentration, for which the color changes from violet to red can be visualized by bare eyes as well be characterized using transmission electron microscopy, UV–visible spectroscopy, and zeta potential analyzer. Cr6+ solutions prepared in phosphate buffer were acid digested to oxidize total chromium to Cr6+. A good linear calibration was noted for longitudinal surface plasmon peak shift (Δλmax) plotted against Cr6+ concentrations with a detection limit of 0.32 μM (R2 = 0.979; Range: 1–100 μM). The method was applied for Cr6+ spiked in artificial gastric and intestinal fluids and simulated blood plasma with good recovery percentages. Their applicability to test chromium internalized in Cr-tolerant bacterial cells and Cr bound to cell walls and chromium internalized in human cells was determined. Hence, the present method can be used as an alternative for Cr6+ analysis in biological matrices.

Liquid Chromatography-Tandem Mass Spectrometry Analysis of Biomarkers of Exposure to Phosphorus Flame Retardants in Wastewater to Monitor Community-Wide Exposure.

Phosphorus flame retardants and plasticizers (PFRs) are increasingly used in consumer goods, from which they can leach and pose potential threats to human health. Monitoring human exposure to these compounds is thus highly relevant. Current assessment of exposure through analysis of biological matrices is, however, tedious as well as logistically and financially demanding. Analysis of selected biomarkers of exposure to PFRs in wastewater could be a simple and complementary approach to monitoring, over space and time, exposure at the population level. An analytical procedure, based on solid-phase extraction (SPE) and liquid chromatography coupled to tandem mass spectrometry, was developed and validated to monitor the occurrence in wastewater of human exposure biomarkers of 2-ethylhexyldiphenyl phosphate (EHDPHP), tris(2-butoxyethyl) phosphate (TBOEP), triphenyl phosphate (TPHP), tris(2-chloroisopropyl) phosphate (TCIPP), and tris(2-chloroethyl) phosphate (TCEP). Various SPE sorbents and extraction protocols were evaluated, and for the optimized method, absolute extraction recoveries ranged between 46% and 100%. Accuracy and precision were satisfactory for the selected compounds. Method detection limits ranged from 1.6 to 19 ng L-1. Biomarkers of exposure to PFRs were measured for the first time in influent wastewater. Concentrations in samples collected in Belgium ranged from below the limit of quantitation to 1072 ng L-1, with 2-ethylhexyl phenyl phosphate (EHPHP) and TCEP being the most abundant. Per capita loads of target biomarkers varied greatly, suggesting potential differences in exposure between the investigated communities. The developed method allowed implementation of the concepts of human biomonitoring at the community scale, opening the possibility to assess population-wide exposure to PFRs.

Imatinib quantification in human serum with LC-MS3 as an effective way of protein kinase inhibitor analysis in biological matrices.

As imatinib gained a lot of attention in the field of medicine, appropriate methods are needed for drug analysis. LC-MS/MS combined with complex sample preparation and column enrichment is usually the method of choice when high sensitivity is necessary. The application of LC-MS3 in imatinib quantification has not been discussed in the literature. An LC-MS3 imatinib quantification method was developed and validated in human serum. The sample preparation was based on the liquid-liquid extraction of 50 μL human serum. Chromatographic separation was performed using a Luna 5 μm C18 (2) 100 A, 150 mm×2 mm column and the elution was done using a mobile phase consisting of A (H2O/methanol=95/5, v/v) and B (H2O/methanol=3/97, v/v), both with 10 mM ammonium acetate and 0.1% acetic acid. The conditions applied resulted in a limit of detection/quantification value of 0.14/0.45 ng/mL reached without a sophisticated sample preparation technique or enrichment column application. It could be demonstrated that MS3 detection is a very effective way of sensitive imatinib quantification. Further, it could be stated that the strategy presented can be very useful for a sensitive analysis of other protein kinase inhibitors, because their molecule structure is appropriate for MS3 detection. The presented analytical strategy is an effective way of protein kinase inhibitor analysis in human serum.

Capillary electrophoresis mass spectrometry as a tool for untargeted metabolomics.

Highly polar and ionic metabolites, such as sugars, most amino acids, organic acids or nucleotides are not retained by conventional reversed-phase LC columns and polar stationary phases and hydrophilic-interaction LC lacks of robustness, which is still limiting their applications for untargeted metabolomics where reproducibility is a must. Biological samples such as blood, urine or even tissues include many hydrophilic compounds secreted from cells, their analysis is essential for biomarker discovery, disease progression or treatment effects. This review focuses on CE coupled to MS as a mature technique for untargeted metabolomics including sample pretreatment, types of matrices, analytical methods, applications and data treatment strategies for polar compound analysis in biological matrices. The main applications and results of CE-MS in untargeted metabolomics are discussed and presented in a tabulated format.

Topiramate: a review of analytical approaches for biological matrices.

Topiramate is an anticonvulsant drug and it has been used worldwide for a wide range of applications. It is mainly indicated for the treatment of partial and generalized seizures, including Lennox Gastant Syndrome and generalized tonic-clonic seizures, and prophylactic treatment of migraine. Different analytical approaches by high-performance liquid chromatography have been described to analyze topiramate because of its lack of chromophore groups, including derivatization with UV-absorbing moieties, derivatization with fluorescent moieties, refractive index detection, conductivity detection, chemiluminescent nitrogen detection, evaporative light scattering detection and MS detection. In addition, some methods for determination of topiramate by capillary electrophoresis have been published as well as by gas chromatography. Thus, it is beneficial to evaluate and compare these papers before selecting the most suitable method/detector to analyze this drug. This systematic review provides a description of the main analytical methods available for the analysis of topiramate in biological matrices. Each of these methods is briefly discussed considering the detector used with HPLC. HPLC coupled with MS is the main technique used for topiramate analysis in biological matrices, mainly in the electrospray ionization-negative mode.

Development and validation of a liquid-chromatography tandem mass spectrometry method to determine in vitro and in vivo histamine release

Histamine is an important biogenic amine involved in regulating numerous physiological and pathophysiological processes in humans and animals. To date, there have been very few studies focused on developing and validating sensitive liquid-chromatography–tandem mass spectrometric (LC–MS/MS) assays capable of quantitative trace level histamine analysis in biological matrices. In the present study, a rapid and sensitive LC–MS/MS assay, amenable to high throughput analysis was developed and validated to characterize in vitro and in vivo histamine release. The LC–MS/MS procedure incorporating deuterium labeled internal standards provides rapid resolution of histamine with excellent sensitivity, precision, and accuracy. Histamine eluted at 1.5min and was well separated from endogenous plasma peaks. The total run time of the assay was 8.0min. A linear (r2≥0.99) instrument response over the entire concentration range of 1.0–1000ng/mL was observed. Excellent accuracy (error±3.4%) and precision (CV±10%) of the assay was demonstrated, with the lower limit of quantitation (LLOQ) at 15.6ng/mL. The validated LC–MS/MS assay was applied to determine histamine release in both in vitro and in vivo models. Peritoneal mast cells treated with prototypical degranulating agents (Compound 48/80 and Teicoplanin) showed that the two chemicals caused approximately 40% histamine release. In rats, using this assay, basal histamine plasma levels were typically under 100ng/mL. Treatment with an agent suspected of causing anaphylactic type reactions resulted in plasma histamine levels to increase above 3000ng/mL. The LC–MS/MS assay presented in this study can be applied to further characterize the physiological and pathophysiological role of histamine release in complex in vitro and in vivo models. Importantly, the LC–MS/MS assay may be useful in assessing active pharmaceutical ingredient-mediated degranulation and anaphylaxis as part of either a pre-market or a post-market assessment of drug products.

Matrix effect in F₂-isoprostanes quantification by HPLC-MS/MS: a validated method for analysis of iPF₂α-III and iPF₂α-VI in human urine.

Liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS) has become the method of choice for analysis in biological matrices, because of its high specificity and sensitivity. However, it should be taken into account that the presence of matrix components coeluting with analytes might interfere with the ionization process and affect the accuracy and precision of the assay. For this reason, the presence of a "matrix effect" should always be evaluated during method development, above all in complex matrix such as urine. In the present work, a HPLC-MS/MS method was developed for the quantification of urinary iPF2α-III and iPF2α-VI. A careful assessment of matrix effect and an accurate validation were carried out, in order to verify the reliability of quantitative data obtained. Ion suppression, due to the matrix components, was reduced through optimization of both chromatographic method and sample extraction procedure. Urine samples were purified by solid phase extraction (SPE) and the extracts injected into the HPLC-MS/MS system, equipped with a TurboIonSpray ionization source operated in negative ion mode (ESI(-)). Stable isotope-labeled analogues (iPF2α-III-d4 and iPF2α-VI-d4) were used as internal standards, and quantification was performed in multiple reaction monitoring (MRM) mode by monitoring the following mass transitions: m/z 353.4→193.2 for iPF2α-III, m/z 357.2→197.0 for iPF2α-III-d4, m/z 353.4→115.1 for iPF2α-VI, and m/z 357.4→115.1 for iPF2α-VI-d4. The validated assay, applied to the analysis of urinary samples coming from healthy and overweight subjects, resulted suitable for an accurate quantification of iPF2α-III and iPF2α-VI in human urine.

Methodological aspects of an off‐line combination of preparative isotachophoresis and high‐performance liquid chromatography with mass spectrometry in the analysis of biological matrices

This work reports on some methodological aspects of an off-line combination of preparative ITP and HPLC with mass spectrometric detection (pITP-HPLC-MS) and its potential applications to the analysis of high molecular mass compounds present in complex biological matrices from the analytical chemistry perspective. Lysozyme served as the model analyte and human saliva as the complex biological matrix in this study. A mixture of five low-molecular mass compounds was found and successfully used in the pITP experiments as discrete spacers to isolate the analyte from the interferents present in the complex biological matrix and to minimize their disturbance effect on the final MS analysis. The experiments at the pITP stage were performed in the cationic mode. On-column conductivity detectors were used for the detection of ITP zones. Lysozyme was found in the human saliva samples using just deconvolution of the MS data after background correction. The MS data obtained from HPLC-MS analysis of pITP fractions exhibited the great analytical potential of the combination of pITP-HPLC-MS resulting from the ITP clean-up effect as well as the ITP preconcentration of the analyte present at low concentration levels in complex biological matrices.